Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt N/A
WAT's Cash to Debt is ranked higher than
76% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. WAT: N/A )
Ranked among companies with meaningful Cash to Debt only.
WAT' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 1.21 Max: 198.95
Current: N/A
0
198.95
Equity to Asset 0.48
WAT's Equity to Asset is ranked lower than
71% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. WAT: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
WAT' s Equity to Asset Range Over the Past 10 Years
Min: 0.13  Med: 0.46 Max: 0.66
Current: 0.48
0.13
0.66
Interest Coverage 16.82
WAT's Interest Coverage is ranked higher than
55% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.00 vs. WAT: 16.82 )
Ranked among companies with meaningful Interest Coverage only.
WAT' s Interest Coverage Range Over the Past 10 Years
Min: 5.71  Med: 16.44 Max: 35.92
Current: 16.82
5.71
35.92
F-Score: 7
Z-Score: 6.14
M-Score: -2.55
WACC vs ROIC
5.85%
33.76%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 27.23
WAT's Operating margin (%) is ranked higher than
93% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.20 vs. WAT: 27.23 )
Ranked among companies with meaningful Operating margin (%) only.
WAT' s Operating margin (%) Range Over the Past 10 Years
Min: 23.05  Med: 26.75 Max: 28.55
Current: 27.23
23.05
28.55
Net-margin (%) 22.70
WAT's Net-margin (%) is ranked higher than
95% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.71 vs. WAT: 22.70 )
Ranked among companies with meaningful Net-margin (%) only.
WAT' s Net-margin (%) Range Over the Past 10 Years
Min: 17.36  Med: 22.34 Max: 25.03
Current: 22.7
17.36
25.03
ROE (%) 23.53
WAT's ROE (%) is ranked higher than
92% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. WAT: 23.53 )
Ranked among companies with meaningful ROE (%) only.
WAT' s ROE (%) Range Over the Past 10 Years
Min: 23.6  Med: 38.77 Max: 68.79
Current: 23.53
23.6
68.79
ROA (%) 11.30
WAT's ROA (%) is ranked higher than
87% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. WAT: 11.30 )
Ranked among companies with meaningful ROA (%) only.
WAT' s ROA (%) Range Over the Past 10 Years
Min: 11.52  Med: 15.50 Max: 18.41
Current: 11.3
11.52
18.41
ROC (Joel Greenblatt) (%) 85.73
WAT's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. WAT: 85.73 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WAT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 72.34  Med: 86.76 Max: 99.06
Current: 85.73
72.34
99.06
Revenue Growth (3Y)(%) 5.90
WAT's Revenue Growth (3Y)(%) is ranked higher than
55% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. WAT: 5.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WAT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.2  Med: 8.90 Max: 17.8
Current: 5.9
5.2
17.8
EBITDA Growth (3Y)(%) 7.00
WAT's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. WAT: 7.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
WAT' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 11.00 Max: 69.2
Current: 7
2.4
69.2
EPS Growth (3Y)(%) 2.90
WAT's EPS Growth (3Y)(%) is ranked lower than
55% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. WAT: 2.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WAT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.6  Med: 14.65 Max: 79.9
Current: 2.9
2.6
79.9
» WAT's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

WAT Guru Trades in Q1 2015

John Hussman 27,000 sh (New)
Chuck Royce 15,450 sh (+16.60%)
Ruane Cunniff 2,049,264 sh (+0.01%)
Paul Tudor Jones Sold Out
PRIMECAP Management 973,611 sh (-0.22%)
Jim Simons 415,100 sh (-16.09%)
Jeremy Grantham 137,415 sh (-16.42%)
Joel Greenblatt 46,450 sh (-17.63%)
Pioneer Investments 2,825 sh (-82.89%)
» More
Q2 2015

WAT Guru Trades in Q2 2015

Paul Tudor Jones 5,788 sh (New)
Ray Dalio 3,665 sh (New)
Joel Greenblatt 89,108 sh (+91.84%)
Ruane Cunniff 2,050,465 sh (+0.06%)
Chuck Royce 15,450 sh (unchged)
Pioneer Investments Sold Out
Jeremy Grantham 128,515 sh (-6.48%)
John Hussman 20,000 sh (-25.93%)
PRIMECAP Management 711,722 sh (-26.90%)
Jim Simons 114,685 sh (-72.37%)
» More
Q3 2015

WAT Guru Trades in Q3 2015

Jim Simons 294,800 sh (+157.05%)
Ray Dalio 8,904 sh (+142.95%)
John Hussman 20,000 sh (unchged)
Ruane Cunniff 2,038,353 sh (-0.59%)
Chuck Royce 14,437 sh (-6.56%)
PRIMECAP Management 657,721 sh (-7.59%)
Paul Tudor Jones 5,300 sh (-8.43%)
Jeremy Grantham 54,090 sh (-57.91%)
Joel Greenblatt 25,527 sh (-71.35%)
» More
Q4 2015

WAT Guru Trades in Q4 2015

Jim Simons 296,696 sh (+0.64%)
Chuck Royce 14,437 sh (unchged)
Joel Greenblatt Sold Out
Ray Dalio Sold Out
PRIMECAP Management 651,117 sh (-1.00%)
Ruane Cunniff 1,995,247 sh (-2.11%)
John Hussman 15,000 sh (-25.00%)
Jeremy Grantham 36,790 sh (-31.98%)
Paul Tudor Jones 3,200 sh (-39.62%)
» More
» Details

Insider Trades

Latest Guru Trades with WAT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.27
WAT's P/E(ttm) is ranked higher than
61% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.55 vs. WAT: 23.27 )
Ranked among companies with meaningful P/E(ttm) only.
WAT' s P/E(ttm) Range Over the Past 10 Years
Min: 9.62  Med: 20.79 Max: 32.19
Current: 23.27
9.62
32.19
Forward P/E 19.16
WAT's Forward P/E is ranked higher than
58% of the 38 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.16 vs. WAT: 19.16 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.27
WAT's PE(NRI) is ranked higher than
62% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.55 vs. WAT: 23.27 )
Ranked among companies with meaningful PE(NRI) only.
WAT' s PE(NRI) Range Over the Past 10 Years
Min: 9.61  Med: 20.78 Max: 32.25
Current: 23.27
9.61
32.25
Price/Owner Earnings (ttm) 23.18
WAT's Price/Owner Earnings (ttm) is ranked higher than
63% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.94 vs. WAT: 23.18 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
WAT' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 9.88  Med: 20.93 Max: 34.46
Current: 23.18
9.88
34.46
P/B 5.14
WAT's P/B is ranked lower than
76% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.68 vs. WAT: 5.14 )
Ranked among companies with meaningful P/B only.
WAT' s P/B Range Over the Past 10 Years
Min: 4.38  Med: 6.47 Max: 19.91
Current: 5.14
4.38
19.91
P/S 5.37
WAT's P/S is ranked lower than
78% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. WAT: 5.37 )
Ranked among companies with meaningful P/S only.
WAT' s P/S Range Over the Past 10 Years
Min: 2.06  Med: 4.40 Max: 5.65
Current: 5.37
2.06
5.65
PFCF 23.94
WAT's PFCF is ranked higher than
62% of the 78 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.31 vs. WAT: 23.94 )
Ranked among companies with meaningful PFCF only.
WAT' s PFCF Range Over the Past 10 Years
Min: 9.71  Med: 21.05 Max: 30.1
Current: 23.94
9.71
30.1
POCF 19.54
WAT's POCF is ranked lower than
63% of the 100 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.04 vs. WAT: 19.54 )
Ranked among companies with meaningful POCF only.
WAT' s POCF Range Over the Past 10 Years
Min: 7.86  Med: 17.17 Max: 24.72
Current: 19.54
7.86
24.72
EV-to-EBIT 17.20
WAT's EV-to-EBIT is ranked higher than
62% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.75 vs. WAT: 17.20 )
Ranked among companies with meaningful EV-to-EBIT only.
WAT' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.1  Med: 16.20 Max: 23.6
Current: 17.2
8.1
23.6
EV-to-EBITDA 14.91
WAT's EV-to-EBITDA is ranked higher than
51% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.31 vs. WAT: 14.91 )
Ranked among companies with meaningful EV-to-EBITDA only.
WAT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7  Med: 14.00 Max: 20.6
Current: 14.91
7
20.6
PEG 3.33
WAT's PEG is ranked lower than
60% of the 60 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.76 vs. WAT: 3.33 )
Ranked among companies with meaningful PEG only.
WAT' s PEG Range Over the Past 10 Years
Min: 0.58  Med: 1.59 Max: 3.73
Current: 3.33
0.58
3.73
Shiller P/E 30.23
WAT's Shiller P/E is ranked higher than
69% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.71 vs. WAT: 30.23 )
Ranked among companies with meaningful Shiller P/E only.
WAT' s Shiller P/E Range Over the Past 10 Years
Min: 16.82  Med: 29.86 Max: 52.03
Current: 30.23
16.82
52.03
Current Ratio 5.70
WAT's Current Ratio is ranked higher than
85% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.64 vs. WAT: 5.70 )
Ranked among companies with meaningful Current Ratio only.
WAT' s Current Ratio Range Over the Past 10 Years
Min: 1.25  Med: 1.94 Max: 5.7
Current: 5.7
1.25
5.7
Quick Ratio 5.23
WAT's Quick Ratio is ranked higher than
88% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. WAT: 5.23 )
Ranked among companies with meaningful Quick Ratio only.
WAT' s Quick Ratio Range Over the Past 10 Years
Min: 0.74  Med: 1.63 Max: 5.23
Current: 5.23
0.74
5.23
Days Inventory 116.41
WAT's Days Inventory is ranked higher than
58% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.92 vs. WAT: 116.41 )
Ranked among companies with meaningful Days Inventory only.
WAT' s Days Inventory Range Over the Past 10 Years
Min: 96.3  Med: 107.44 Max: 110.42
Current: 116.41
96.3
110.42
Days Sales Outstanding 77.99
WAT's Days Sales Outstanding is ranked lower than
72% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.57 vs. WAT: 77.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
WAT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.61  Med: 79.15 Max: 83.7
Current: 77.99
67.61
83.7
Days Payable 30.14
WAT's Days Payable is ranked lower than
80% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. WAT: 30.14 )
Ranked among companies with meaningful Days Payable only.
WAT' s Days Payable Range Over the Past 10 Years
Min: 26.08  Med: 29.67 Max: 35.98
Current: 30.14
26.08
35.98

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.16
WAT's Price/Tangible Book is ranked lower than
73% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.11 vs. WAT: 7.16 )
Ranked among companies with meaningful Price/Tangible Book only.
WAT' s Price/Tangible Book Range Over the Past 10 Years
Min: 6.38  Med: 12.47 Max: 46.51
Current: 7.16
6.38
46.51
Price/Projected FCF 1.74
WAT's Price/Projected FCF is ranked higher than
58% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. WAT: 1.74 )
Ranked among companies with meaningful Price/Projected FCF only.
WAT' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.9  Med: 1.64 Max: 11.02
Current: 1.74
0.9
11.02
Price/DCF (Earnings Based) 1.38
WAT's Price/DCF (Earnings Based) is ranked higher than
72% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.07 vs. WAT: 1.38 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.23
WAT's Price/Median PS Value is ranked lower than
61% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. WAT: 1.23 )
Ranked among companies with meaningful Price/Median PS Value only.
WAT' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.52  Med: 1.01 Max: 3.25
Current: 1.23
0.52
3.25
Price/Peter Lynch Fair Value 3.59
WAT's Price/Peter Lynch Fair Value is ranked lower than
72% of the 50 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.47 vs. WAT: 3.59 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
WAT' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.65  Med: 1.59 Max: 3.64
Current: 3.59
0.65
3.64
Price/Graham Number 2.74
WAT's Price/Graham Number is ranked lower than
58% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. WAT: 2.74 )
Ranked among companies with meaningful Price/Graham Number only.
WAT' s Price/Graham Number Range Over the Past 10 Years
Min: 2.35  Med: 3.39 Max: 11.1
Current: 2.74
2.35
11.1
Earnings Yield (Greenblatt) (%) 5.87
WAT's Earnings Yield (Greenblatt) (%) is ranked higher than
77% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. WAT: 5.87 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WAT' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.2  Med: 6.20 Max: 12.4
Current: 5.87
4.2
12.4
Forward Rate of Return (Yacktman) (%) 10.07
WAT's Forward Rate of Return (Yacktman) (%) is ranked higher than
52% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.62 vs. WAT: 10.07 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
WAT' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.9  Med: 15.90 Max: 26.3
Current: 10.07
9.9
26.3

More Statistics

Revenue(Mil) $2057
EPS $ 5.65
Beta0.61
Short Percentage of Float4.31%
52-Week Range $112.00 - 138.92
Shares Outstanding(Mil)81.25

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 2,144 2,265 2,419
EPS($) 6.35 6.94 7.67
EPS without NRI($) 6.35 6.94 7.67

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NYSE:BDX, XPAR:EI, NYSE:BAX, NAS:ILMN, NYSE:BCR, OCSE:COLO B » details
Traded in other countries:WAZ.Germany,
Waters Corp incorporated as a Delaware corporation in 1991, is an analytical instrument manufacturer, mainly designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Waters became a publicly-traded company with its initial public offering ("IPO") in November 1995. The Company's two operating segments, Waters Division and TA Division, have similar economic characteristics; product processes; products and services; types and classes of customers; methods of distribution and regulatory environments. The Waters Division's products and services consist of high performance liquid chromatography ("HPLC"), ultra performance liquid chromatography ("UPLC" and together with HPLC, referred to as "LC"), mass spectrometry ("MS") and chemistry consumable products and related services. TA products and services consist of thermal analysis, rheometry and calorimetry instrument systems and service sales. The Company's products are used by pharmaceutical, life science, biochemical, industrial, nutritional safety, environmental, academic and governmental customers. These customers use the Company's products to detect, identify, monitor and measure the chemical, physical and biological composition of materials and to predict the suitability of fine chemicals, pharmaceuticals, water, polymers and viscous liquids in various industrial, consumer goods and healthcare products. The Company's competitors include: Agilent Technologies, Inc., Shimadzu Corporation, Bruker Corporation, Danaher Corporation and Thermo Fisher Scientific Inc. In the markets served by the TA Division, the Company's principal competitors include: PerkinElmer, Inc., Mettler-Toledo International Inc., NETZSCH-Geraetebau GmbH, Thermo Fisher Scientific Inc., Malvern Instruments Ltd., Anton-Paar and General Electric Company.
» More Articles for NYSE:WAT

Headlines

Articles On GuruFocus.com
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Weekly Insider Sells Highlights: Walgreens Boots Alliance, Waters, Fitbit, Extra Space Storage Nov 24 2015 
Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Our Investment Strategy and Portfolio Selection Nov 09 2014 
Guru-Held Stocks Trading At Historical Low P/B Oct 08 2014 
Guru Held Stocks Near Historical Low P/B Jul 22 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 

More From Other Websites
Waters Corp. breached its 50 day moving average in a Bullish Manner : WAT-US : May 3, 2016 May 03 2016
ETF’s with exposure to Waters Corp. : April 29, 2016 Apr 29 2016
Waters Corp. :WAT-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 27 2016
Edited Transcript of WAT earnings conference call or presentation 26-Apr-16 12:30pm GMT Apr 26 2016
Waters Corp. (WAT) Q1 Earnings Top on Operational Strength Apr 26 2016
Waters Corp Earnings Call scheduled for 8:30 am ET today Apr 26 2016
Waters Corp. (WAT) Q1 Earnings and Revenues Top Estimates Apr 26 2016
Waters tops Street 1Q forecasts Apr 26 2016
Waters tops Street 1Q forecasts Apr 26 2016
WATERS CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 26 2016
Waters Reports First Quarter 2016 Financial Results Apr 26 2016
Q1 2016 Waters Corp Earnings Release - Before Market Open Apr 26 2016
Waters Reports First Quarter 2016 Financial Results Apr 26 2016
Can Waters Corp. (WAT) Keep the Earnings Streak Alive? Apr 22 2016
Waters Corporation Q1 2016 Financial Results Webcast Invitation Apr 05 2016
Waters Corporation Q1 2016 Financial Results Webcast Invitation Apr 05 2016
Waters downgraded by BofA/Merrill Apr 05 2016
Toxicology Laboratory at UC San Diego School of Medicine Joins Waters Center of Innovation Program Mar 17 2016
XLV Falls during a Tough Day for Biotechs Mar 16 2016
Waters Launches Calorimeters & Column Chemistries at Pittcon Mar 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK